Shenzhen - Delayed Quote CNY
Yunnan Baiyao Group Co.,Ltd (000538.SZ)
57.29
+0.50
+(0.88%)
At close: 3:04:12 PM GMT+8
Key Executives
Amounts are as of -- and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in CNY.
| Name | Title | Pay | Exercised | Year Born |
|---|---|---|---|---|
| Mr. Ming Dong | Vice Chairman, President & CEO | -- | -- | 1976 |
| Mr. Jia Ma | Chief Financial Officer | -- | -- | 1977 |
| Mr. Zhang Ning | Chief Scientist | -- | -- | 1970 |
| Mr. Jing Li | Chief Quality & Process Officer | -- | -- | 1965 |
| Mr. Sheng Li Li | Senior Vice President | -- | -- | 1973 |
| Ms. Zhao Yun Zhu | Strategic Scientist of Chinese Medicine | -- | -- | 1954 |
Yunnan Baiyao Group Co.,Ltd
No. 3686, Yunnan Baiyao Street
Chenggong District
Kunming, 650500
China
- Sector:
- Healthcare
- Industry: Drug Manufacturers - Specialty & Generic
- Full Time Employees:
- 9,277
Description
Yunnan Baiyao Group Co.,Ltd engages in the pharmaceutical business in China, Southeast Asia, Europe, the United States, Japan, and internationally. It provides health products; drugs; medical devices; traditional Chinese medicine resources; and tea products. The company also supplies and distributes medicines. Yunnan Baiyao Group Co., Ltd. was founded in 1902 and is based in Kunming, China.
Corporate Governance
Yunnan Baiyao Group Co.,Ltd’s ISS Governance QualityScore as of May 1, 2025 is 3. The pillar scores are Audit: 10; Board: 7; Shareholder Rights: 3; Compensation: 1.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.
Upcoming Events
April 29, 2025 at 10:59 AM UTC
Yunnan Baiyao Group Co.,Ltd Earnings Date
Recent Events
April 30, 2025 at 12:00 AM UTC
Ex-Dividend Date